2015
DOI: 10.1016/j.ygyno.2015.05.019
|View full text |Cite
|
Sign up to set email alerts
|

Significance of monocyte counts on tumor characteristics and survival outcome of women with endometrial cancer

Abstract: Elevated monocyte counts were associated with aggressive tumor features and poor survival outcomes of patients with endometrial cancer.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
25
0

Year Published

2015
2015
2022
2022

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 35 publications
(27 citation statements)
references
References 33 publications
(41 reference statements)
2
25
0
Order By: Relevance
“…The STROBE guidelines were consulted for reporting in a case-control study [4]. Some of the patients in this study were within the context of our previous studies [20][21][22][23][24].…”
Section: Materials and Methods Eligibilitymentioning
confidence: 99%
“…The STROBE guidelines were consulted for reporting in a case-control study [4]. Some of the patients in this study were within the context of our previous studies [20][21][22][23][24].…”
Section: Materials and Methods Eligibilitymentioning
confidence: 99%
“…Similar to our findings in mCRC, elevated preoperative monocytes correlates with a poor prognosis in several human cancers. 15,24,25 Furthermore, neoplastic expression of CCL2 correlates with increased TAM infiltrate and worse prognosis in multiple solid tumors. 16,17,26 Likewise, a high TAM density correlates with decreased survival in breast, pancreatic, liver, and other tumors.…”
Section: Discussionmentioning
confidence: 99%
“…11,12 In addition, an increased number of circulating monocytes have been associated with aggressive tumor behavior and decreased survival in women with endometrial cancer. 13 However, the significance of monocyte levels at recurrence/progression remains unclear in the setting of endometrial cancer. The aim of this study was to examine the association between monocyte counts at the first recurrence/progression and SAR in women with endometrial cancer.…”
mentioning
confidence: 99%